Sinopharm
1099.HK
#2002
Rank
C$11.23 B
Marketcap
$3.60
Share price
-2.43%
Change (1 day)
2.70%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : C$14.59 Billion

According to Sinopharm's latest financial reports the company's total debt is C$14.59 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31C$18.59 B35.99%
2021-12-31C$13.67 B2.07%
2020-12-31C$13.39 B29.95%
2019-12-31C$10.30 B-5.55%
2018-12-31C$10.91 B51.65%
2017-12-31C$7.19 B11.02%
2016-12-31C$6.48 B4.58%
2015-12-31C$6.19 B12.3%
2014-12-31C$5.52 B24.83%
2013-12-31C$4.42 B71.8%
2012-12-31C$2.57 B14.85%
2011-12-31C$2.24 B331.64%
2010-12-31C$0.51 B96.13%
2009-12-31C$0.26 B-9.21%
2008-12-31C$0.29 B-8.06%
2007-12-31C$0.31 B13%
2006-12-31C$0.28 B